Diffuse malignant peritoneal mesothelioma – An update on treatment
Authors:
- Krishna PillaiKPKrishna Pillai
- Terence C. ChuaTCTerence C. Chua
- Mohammad H. PourgholamiMPMohammad H. Pourgholami
- David L. MorrisDMDavid L. Morris
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 38 (6) , 605-612
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Malignant mesothelioma: Facts, Myths, and HypothesesJournal of Cellular Physiology, 2011
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional ExperienceJournal of Clinical Oncology, 2009
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1PClinical Cancer Research, 2009
- Combined Resection, Intraperitoneal Chemotherapy, and Whole Abdominal Radiation for the Treatment of Malignant Peritoneal MesotheliomaAmerican Journal of Clinical Oncology, 2008
- Mesothelin targeted cancer immunotherapyEuropean Journal of Cancer, 2008
- Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesotheliomaThorax, 2007
- Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesotheliomaEuropean Journal of Surgical Oncology, 2006
- Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascitesEuropean Journal of Surgical Oncology, 2006
- Comprehensive management of diffuse malignant peritoneal mesotheliomaEuropean Journal of Surgical Oncology, 2006
- Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesotheliomaEuropean Journal of Surgical Oncology, 2002